drugset / Trial / NCT06264219

Restoration of the Gut Microbiome After Cesarean Section

NCT06264219 ↗

Phase 1 Recruiting 80 enrolled Jakob Stokholm
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This study aims to develop a therapy for restoring the gut microbiome in infants born via CS. The Study will conduct a randomized, placebo-controlled feasibility trial to assess the ability of microbiome restoration by FMT and FVT in infants born by cesarean section.

Timeline

Start
2024-08-02
Primary completion
2027-08-30
Completion
2027-08-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator FMT Other / unclassified — —
Comparator FVT Other / unclassified — —

Indications

No indication recorded.